News

Early referral, school accommodations, and patient education may help improve quality of life for children with hidradenitis suppurativa.

Julie Khlevner, MD, discusses the clinical impact of FDA approval of linaclotide for children aged 2 to 5 years with functional constipation.

FDA approved ensitrelvir for COVID-19 post-exposure prophylaxis in patients aged 12 years and older after positive phase 3 trial results.

Colleen Cotton, MD, FAAD, outlines key skin findings that may help pediatricians distinguish hidradenitis suppurativa from other conditions.

An updated consensus statement from the Society for Maternal-Fetal Medicine confirms that acetaminophen remains the safest first-line treatment for pain and fever during pregnancy.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from May 2026.

Early diagnosis of hidradenitis suppurativa in adolescents may help prevent scarring and improve treatment response, according to Colleen Cotton, MD, FAAD.

The FDA accepted an sNDA for mavacamten in adolescents with obstructive hypertrophic cardiomyopathy, with a decision expected in September 2026.

Kevin Kaiserman, MD, discusses how FDA approval of Afrezza gives children aged 6 years and older with diabetes a new mealtime insulin option.

Clear guidance on formula types, safety rules, imported brands, and ingredient fears—plus when switching helps or harms—to reduce anxiety and support healthy growth.

Cedars-Sinai Guerin Children’s launched a wearable asthma monitoring program designed to help detect worsening respiratory symptoms earlier.

The FDA extended its review of adrabetadex for infantile-onset Niemann-Pick disease type C to November 17, 2026, after a major NDA amendment.

UCLA researchers identified EPAC2 as a potential Fragile X syndrome treatment target after improving behavioral and brain activity patterns in mice.

FDA expanded approval of linaclotide for functional constipation to include children aged 2 to 5 years.

New AAP guidance calls for transparent pay practices and family-friendly policies to address gender-based pay inequities in pediatrics.

FDA approval moves adapalene 0.1% and benzoyl peroxide 2.5% gel to OTC use for acne in patients aged 12 years and older.

Ecopipam lowered relapse risk in pediatric Tourette syndrome responders in phase 3 data supporting a planned FDA submission.

In this episode of Infectious Insights, our host Tina Tan, MD, is joined by Juan C. Salazar, MD, to discuss the rise in measles cases, vaccine hesitancy, and more.

A study found no association with prenatal antibiotic use and only a modest, potentially confounded increase in type 1 diabetes risk following early childhood exposure.

Jon Farber, MD, shares his thoughts on radiocapitellar radiograph for identifying operative elbow fractures.

Adolescents spent an average of 50 minutes on smartphones during school nights, with social media accounting for most use.

Most children with food allergies can maintain adequate nutrition with proper counseling, targeted food substitutions, and routine growth monitoring.

French data suggest dual RSV immunization with RSVpreF and nirsevimab was associated with low infant RSV hospitalization rates.

Yoshi Rothman, MD, said growing leucovorin use in autism highlights the need for larger clinical trials and careful family counseling.

Phase 3 data showed vosoritide significantly improved annualized growth velocity and height outcomes in children with hypochondroplasia.

The hardest part of practicing medicine right now is not the complexity of care. It is earning trust.

Study finds leucovorin prescribing for children with autism increased more than 2,000% after national media coverage and White House promotion.

Children with anxiety, depression, and social needs had higher odds of health-related school absenteeism, according to a new study.